HUMANCLAV-625 Tablets
Description
HUMANCLAV-625 is a high-potency, broad-spectrum antibiotic designed to combat a wide range of bacterial infections. It combines two powerful components: Amoxycillin (500 mg), a penicillin-type antibiotic that kills bacteria by preventing cell wall synthesis, and Potassium Clavulanate (125 mg), a beta-lactamase inhibitor. The addition of Clavulanic Acid is critical because many bacteria have evolved to produce enzymes called beta-lactamases that can deactivate standard Amoxycillin. By inhibiting these enzymes, HUMANCLAV-625 remains effective even against resistant bacterial strains that would otherwise survive treatment.
This medication is highly effective for treating infections of the upper and lower respiratory tracts, including pneumonia, bronchitis, and sinusitis. It is also widely used for urinary tract infections (UTI), skin and soft tissue infections, and dental abscesses. Manufactured in a WHO-GMP certified facility, this product ensures the highest standards of safety and efficacy. Because it is a Schedule H Prescription Drug, it must be taken under strict medical supervision. Completing the full course of treatment is essential to ensure the complete eradication of bacteria and to prevent the dangerous development of antibiotic resistance within the community.
Product Information
| Uses & Benefits | Treats Respiratory infections (Pneumonia, Bronchitis), Ear/Sinus infections, UTI, and Skin infections. |
|---|---|
| Ingredients | Amoxycillin Trihydrate IP (eq. to Amoxycillin $500\text{ mg}$) + Potassium Clavulanate Diluted IP eq. to Clavulanic Acid $125\text{ mg} |
| Dosage | As directed by the Physician; typically taken with food. |
| Side Effects | May cause mild nausea, diarrhea, or skin rash. |
| Safety Information | Schedule H Drug: Not to be sold without a prescription. Store below 25°C |
FAQs
Frequently Asked Questions
This FAQ section addresses common questions regarding private nursing and home care services, it covers essential topics.